• share
• favorite_border

Denny Sanford’s gift launches Sanford Imagenetics.

• share
• favorite_border

The innovative program includes a breast cancer risk assessment tool and a care plan for high-risk patients. Additionally, it will offer patients the opportunity to participate in research aimed at gaining a better understanding of breast cancer and its risk factors, ultimately raising the standard of care for women everywhere. This program marks another milestone in ESBC’s mission to end breast cancer.

• share
• favorite_border

A study addressing how location and sex can affect mouse models in scientific research authored by Sanford Research’s David Pearce, PhD, appears in July’s issue of Scientific Reports.

• share
• favorite_border

New program helps patients at risk for amputations.

• share
• favorite_border

Dr. Bell recently completed her 1,000th robotic surgery, sees superb results through program.

• share
• favorite_border

An eating disorders research team led by Stephen Wonderlich, PhD. has developed a successful bulimia nervosa therapy that can provide patients an alternative for treating this debilitating disorder.

• share
• favorite_border

The Edith Sanford Breast Cancer Foundation and The Scripps Research Institute (TSRI) recently announced a dynamic, interdisciplinary collaboration that will lay the groundwork for significant advancements in personalized breast cancer treatment and care.

• share
• favorite_border

Dr. John Lee’s work in October issue of Cancer Gene Therapy.

• share
• favorite_border

A grant from the National Institutes of Health (NIH) is allowing Sanford Health researchers to explore the origin of cervical cancer in American Indian women.The five-year grant totals nearly $1.6 million. Sanford scientist Subhash Chauhan, PhD, is the principal investigator leading a team of seven researchers.

• share
• favorite_border

Sanford Project researchers have reached a critical milestone in a clinical trial testing a combination of two medications to determine if the drugs can help patients with type 1 diabetes (T1D) keep their blood glucose levels under control with less or no insulin. The full number of patients needed to complete this first trial, termed Restore Pancreatic Insulin Response in type 1 diabetes (REPAIR-T1D), has been reached.

• share
• favorite_border

National Organization on Fetal Alcohol Syndrome Selects H. Eugene Hoyme, MD for its 2012 Excellence Award.

• share
• favorite_border

After conducting an extensive search for a physician-scientist to lead Edith Sanford Breast Cancer Research, Sanford Health has hired internationally renowned breast cancer researcher and clinician, Brian Leyland-Jones, MB BS, PhD, to lead this new breast cancer genomic research program and state-of-the-art breast cancer center.

• share
• favorite_border

Sanford Health Children’s Research Center researcher, Kyle Roux, PhD, has revealed a new method of research that will allow the cause of disease—particularly rare diseases—to become more easily identified. Called BioID, this method identifies the proximity and interactions between proteins in living cells providing insight into the underlying mechanisms of disease. Ultimately, this method could lead to the development of more targeted therapeutic or novel treatments for patients.